Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PediatRx signs pact with Bi-Coastal Pharma for Aquoral
The US Food and Drug Administration (FDA) approved Aquoral is indicated for the treatment of xerostomia. PediatRx founder Cameron Durrant said they expect that Aquoral will help further
The US Food and Drug Administration (FDA) approved Aquoral is indicated for the treatment of xerostomia. PediatRx founder Cameron Durrant said they expect that Aquoral will help further
Vibativ is an once-daily injectable lipoglycopeptide antibacterial agent with a dual mechanism of action against Gram-positive bacteria, including resistant pathogens such as methicillin-resistant Staphylococcus aureus (MRSA). Astellas Pharma
In two Phase 1a studies, AVL-292 demonstrated a favorable safety, tolerability and pharmacokinetic profile in healthy volunteers. The trial is investigating the pharmacokinetics, safety and tolerability profile of
The grant is expected to support the validation and prioritization of several lead CFCL chemical classes, drugs targeting the most common cystic fibrosis (CF) disease-causing mutation. DBM expects
iCentera is a provider of SaaS-based sales enablement solutions. The iCentera platform provides easy-to-use solutions for business users that incorporate automated content management, portal creation, and built-in trend
Thorne Bariatric nutritional product line is made of natural sweeteners and flavorings and is aspartame-free and sucralose-free. The product line includes ImmunoLin, which enhances gastrointestinal and immune health
The company expects to recruit around 225 patients in the study to investigate the efficacy and safety of weekly injections of CJC-1134-PC for 17 weeks. The trial also
The study also demonstrated that vildagliptin added to current therapy resulted in significant improvements in glycemic control. The data showed that the overall safety and tolerability of vildagliptin
Lupin’s levetiracetam 500mg and 750mg extended-release tablets are generic equivalent to Keppra XR tablets of UCB. Keppra is indicated for the treatment of partial onset seizures in patients
The study aimed at assessing the safety, tolerability and pharmacokinetics of a single administration of BL-1021 at doses between 10mg and 80mg. The preliminary modeling of the pharmacokinetic